Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%)
< Home < Back

Dr. Reddy’s Laboratories receives EIR from USFDA

Date: 23-08-2018

Dr. Reddy’s Laboratories has received an Establishment Inspection Report (EIR) from the United States Food & Drug Administration (USFDA), for API Srikakulam Plant (SEZ) Andhra Pradesh.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.